Mucocort

Mucocort AB is a Swedish MedTech company based at the Umeå Biotech Incubator that specializes in developing innovative treatments for oral mucosal diseases. The company's lead product, M045A, is a patented, biodegradable, mucoadhesive patch designed to treat recurrent aphthous stomatitis (mouth ulcers) by providing rapid pain relief and accelerating the natural healing process. M045A works through a unique dual mechanism: a powerful hygroscopic effect that absorbs inflammatory exudate and a non-pharmacological action that suppresses pro-inflammatory cytokines such as TNF-alpha and IL-2. Operating as a virtual organization, Mucocort leverages a network of experts and strategic partnerships, including a manufacturing agreement with Aurena Laboratories. The company is currently in the clinical stage and is actively seeking strategic partners or acquirers to bring its validated technology to the global market.